← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2011Last known activity
Nov 21, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 7 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT06708520OfficialPhase 1Nov 21, 2022
- NCT06736340OfficialPhase 1Nov 17, 2022
- NCT05676684CollaboratorPhase 2/Phase 3Sep 15, 2022
- NCT05140057Lead sponsorN/ADec 1, 2021
- NCT05140057Reponsible party - principal investigatorN/ADec 1, 2021
- NCT03534895CollaboratorPhase 4May 31, 2019
- NCT02017561CollaboratorPhase 2Jan 1, 2014
- NCT01567306Overall official - principal investigatorPhase 2Oct 1, 2011
Details
- Last known activity
- Nov 21, 2022